Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -509.36% is 82% below its 3-year average of -279.97%, near the low end of its 3-year range (-509.36%–-140.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 78.78% below its 12-month average of -284.92%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -509.36%.
RETURN ON EQUITY (ROE)
-509.36%
RETURN ON EQUITY (ROE) AVG TTM
-284.92%
RETURN ON EQUITY (ROE) AVG 3Y
-269.76%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-78.78%
CURRENT VS 3Y AVG
-88.82%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.06%
median of 381 covered companies
CURRENT VS SECTOR MEDIAN
-1440.72%
vs the sector median at left
Autonomix Medical, Inc.
Market Cap
$1.92M
Return on Equity (ROE)
-509.36%
TTM Avg
-284.92%
3Y Avg
-269.76%
5Y Avg
N/A
Market Cap
$1.54M
Return on Equity (ROE)
-450.54%
TTM Avg
292.29%
3Y Avg
55.45%
5Y Avg
24.80%
Market Cap
$2.36M
Return on Equity (ROE)
-1160.10%
TTM Avg
-528.10%
3Y Avg
-389.86%
5Y Avg
-336.02%
Market Cap
$1.49M
Return on Equity (ROE)
-80.57%
TTM Avg
-96.07%
3Y Avg
-115.92%
5Y Avg
51.19%
Market Cap
$2.37M
Return on Equity (ROE)
-69.79%
TTM Avg
-83.20%
3Y Avg
-70.37%
5Y Avg
-0.36%
Market Cap
$1.37M
Return on Equity (ROE)
-111.51%
TTM Avg
-753.43%
3Y Avg
-507.39%
5Y Avg
-356.28%
Market Cap
$2.47M
Return on Equity (ROE)
-391.26%
TTM Avg
-355.49%
3Y Avg
-474.62%
5Y Avg
-295.97%
Market Cap
$1.36M
Return on Equity (ROE)
-253.57%
TTM Avg
334.28%
3Y Avg
134.39%
5Y Avg
95.16%
Market Cap
$2.59M
Return on Equity (ROE)
-402.92%
TTM Avg
-276.14%
3Y Avg
-197.40%
5Y Avg
-116.89%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | $1.92M | -509.36% | -284.92% | -269.76% | N/A |
| Curis, Inc. (CRIS)vs › | $1.54M | -450.54% | 292.29% | 55.45% | 24.80% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | -1160.10% | -528.10% | -389.86% | -336.02% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -80.57% | -96.07% | -115.92% | 51.19% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.37M | -69.79% | -83.20% | -70.37% | -0.36% |
| Genprex, Inc. (GNPX)vs › | $1.37M | -111.51% | -753.43% | -507.39% | -356.28% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | -391.26% | -355.49% | -474.62% | -295.97% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | -253.57% | 334.28% | 134.39% | 95.16% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | -402.92% | -276.14% | -197.40% | -116.89% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | N/A | 558.67% | 54.46% | -8.27% |
ROE
-509.4%
ROA
-404.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -509.36% |
| 2026-03-31 | -283.55% |
| 2025-12-31 | -201.38% |
| 2025-09-30 | -258.98% |
| 2025-06-30 | -171.32% |
| 2025-03-31 | -140.87% |
| 2024-12-31 | -140.37% |
| 2024-09-30 | -463.24% |
| 2024-06-30 | -326.34% |
| 2024-03-31 | -202.23% |
| 2023-03-31 | -382.02% |
